Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM6CH2Drugs primarily affecting the autonomic nervous system
Adrenergic antagonists
Beta-adrenoreceptor antagonists
XM9MF0Beta-adrenoreceptor antagonists, selective

XM44F9 category

Landiolol

Also indexed as

Landiolol

Nearby in Beta-adrenoreceptor antagonists, selective

XM9VG1Practolol
XM8L21Metoprolol
XM0M62Atenolol
XM0V36Acebutolol
XM7U87Betaxolol
XM0HY3Bevantolol
XM8QC9Bisoprolol
XM54E1Celiprolol

PreviousXM3156 — Talinolol

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM26S4Hormones and their synthetic substitutes or antagonists, not elsewhere classified
XM9W63Agents affecting bones, joints or other connective tissue, not elsewhere classified
XM4TG8Agents primarily affecting water and nutrition-balance or metabolism
XM3973Agents primarily affecting the cardiovascular system
XM6CH2Drugs primarily affecting the autonomic nervous system
XM7YD4Drugs used in addictive disorders
XM8014Antivertigo and motion sickness preparations
XM1950Agents primarily acting on smooth and skeletal muscles or the respiratory system
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
14 more
Adrenergic agonists
Adrenergic antagonists
Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
Parasympathomimetics [cholinergics]
Ganglionic blocking drugs
Alpha-adrenoreceptor antagonists
Beta-adrenoreceptor antagonists
XM77E7Alpha and beta blocking agents, antagonists
XM7R98Beta-adrenoreceptor antagonists, non selective
XM9MF0Beta-adrenoreceptor antagonists, selective
XM5S93Beta adrenergic blocking agent, heart
XM8026Bunitrolol
XM3N87Carazolol
XM7V19Indenolol
XM91L7Pronetalol
XM77W2Tolamolol
XM9VG1Practolol
XM8L21Metoprolol
XM0M62Atenolol
XM0V36Acebutolol
XM7U87Betaxolol
XM0HY3Bevantolol
XM8QC9Bisoprolol
XM54E1Celiprolol
XM4AB1Esmolol
XM1T80Epanolol
XM7115S-atenolol
XM0995Nebivolol
XM3156Talinolol
XM44F9Landiolol

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact